Physician

Ray Harvey Mclaughlin, M.D.

According to 2025 Medicare claims, Ray Mclaughlin, M.D. (NPI: 1720215049) practices rheumatology in the Daphne-Fairhope-Foley, AL market, with the plurality of this provider's patient population coming from Baldwin, AL. This provider's primary affiliated billing organization is IMC-DIAGNOSTIC AND MEDICAL CLINIC LLC (NPI: 1447201066; TIN: 631012832) and primary practice location at 36526-8945. Mclaughlin is affiliated with the Ochsner Accountable Care Network, LLC (ACO ID: A1535), participating under the MSSP model.

Mclaughlin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 528 traditional Medicare patients, billed 219,897 HCPCS/CPT codes, and received $982,396 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 7,329 prescription claims across 1,124 beneficiaries totaling $12,925,800 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2023 DME data shows 12 claims. Open Payments data shows 199 records totaling $73,044. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $35,958 to $982,396. Similarly, Part D prescription costs have moved sharply higher in recent years, from $131,521 to $12,925,800. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$543K$1.1M2015 Medicare payment: $35,958 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $372,598 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $598,344 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,086,183 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $934,375 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $548,461 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $624,488 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $823,679 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $877,172 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $982,396 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151261,508$35,958
201638723,152$372,598
201736737,553$598,344
201850368,974$1,086,183
201955062,041$934,375
202052163,079$548,461
202150380,745$624,488
2022533143,387$823,679
2023533175,894$877,172
2024528219,897$982,396

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$6.5M$13M2015 Drug cost: $131,521 (USD; Tot_Drug_Cst)2016 Drug cost: $1,455,778 (USD; Tot_Drug_Cst)2017 Drug cost: $2,710,356 (USD; Tot_Drug_Cst)2018 Drug cost: $4,246,423 (USD; Tot_Drug_Cst)2019 Drug cost: $5,089,690 (USD; Tot_Drug_Cst)2020 Drug cost: $5,781,705 (USD; Tot_Drug_Cst)2021 Drug cost: $7,343,214 (USD; Tot_Drug_Cst)2022 Drug cost: $8,723,121 (USD; Tot_Drug_Cst)2023 Drug cost: $11,694,715 (USD; Tot_Drug_Cst)2024 Drug cost: $12,925,800 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015175535$131,521
20164863,623$1,455,778
20176304,960$2,710,356
20187705,079$4,246,423
20198615,633$5,089,690
20209036,197$5,781,705
20219806,624$7,343,214
20221,0146,661$8,723,121
20231,0596,713$11,694,715
20241,1247,329$12,925,800

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$97$1952023 Medicare payment: $195 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R12$195
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more399694$79
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's381549$11
36415Insertion of needle into vein for collection of blood sample329510$9
86140Measurement c-reactive protein for detection of infection or inflammation353548$5
85652Red blood cell sedimentation rate, to detect inflammation, automated350546$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab2487,280$2,078,006
RinvoqUpadacitinib2658,550$1,760,630
KevzaraSarilumab41011,481$1,713,364
Enbrel SureclickEtanercept1865,320$1,353,110
Orencia ClickjectAbatacept1775,096$991,766

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.199$73,044UCB, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ray Harvey Mclaughlin, M.D.?

Tedicare shows public-source Medicare data for Ray Harvey Mclaughlin, M.D. (NPI 1720215049), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ray Harvey Mclaughlin, M.D. have ACO affiliation data?

Ray Harvey Mclaughlin, M.D. is shown with ACO affiliation data for Ochsner Accountable Care Network, LLC (MSSP, ACO ID A1535).

What billing organization is linked to Ray Harvey Mclaughlin, M.D.?

Ray Harvey Mclaughlin, M.D. is linked to IMC-DIAGNOSTIC AND MEDICAL CLINIC LLC (billing NPI 1447201066) in the available physician profile data.

Does Ray Harvey Mclaughlin, M.D. have Open Payments data?

Ray Harvey Mclaughlin, M.D. has 199 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.